ConductScience.org, home

Paper4170754

Bacterial precipitins in serum of patients with cystic fibrosis.

Burns MW and 1 other. Lancet, 1968. Cited by 104 papers, by iCite.

Cite this record

ConductScience Library. Bacterial precipitins in serum of patients with cystic fibrosis. Papers, record 4170754. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4170754

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Bacterial precipitins in serum of patients with cystic fibrosis.
PubMed
Journal
Lancet
PubMed
Year
1968
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
104
iCite
Revised in PubMed
2019-06-11
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Burns MWM W
2May JRJ R

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cystic FibrosisMajor topic
PrecipitinsMajor topic
Respiratory Tract InfectionsMajor topic
Adolescent
Adult
Bronchiectasis
Bronchitis
Child
Haemophilus influenzae
Humans
Immunoelectrophoresis
Influenza, Human
Neutralization Tests
Pneumococcal Infections
Precipitin Tests
Pseudomonas Infections
Pseudomonas aeruginosa
Staphylococcal Infections
Staphylococcus
Streptococcus pneumoniae

Source PubMed

Download CSV of topics

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 104 citations.

PMIDTitleJournalYearIn PapersSource
36206247Limited evidence of patient-to-patient transmission of Staphylococcus aureus strains between children with cystic fibrosis, Queensland, Australia.PLoS One2022https://conductscience.org/library/papers/36206247PubMed
16601093Diagnostic value of serological tests against Pseudomonas aeruginosa in a large cystic fibrosis population.Thorax2006https://conductscience.org/library/papers/16601093PubMed
16557868Agar-Gel Precipitating Antibody in Pseudomonas aeruginosa Infections.Infect Immun1970https://conductscience.org/library/papers/16557868PubMed
11932230Lung infections associated with cystic fibrosis.Clin Microbiol Rev2002https://conductscience.org/library/papers/11932230PubMed
8840786Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.Microbiol Rev1996https://conductscience.org/library/papers/8840786PubMed
7436516Gentamicin and tobramycin compared in the treatment of mucoid pseudomonas lung infections in cystic fibrosis.Arch Dis Child1980https://conductscience.org/library/papers/7436516PubMed
6778898Antiphagocytic effect of Pseudomonas aeruginosa exopolysaccharide.J Clin Pathol1980https://conductscience.org/library/papers/6778898PubMed
6413411Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis.Infect Immun1983https://conductscience.org/library/papers/6413411PubMed
6404824Chronic colonization of rat airways with Pseudomonas aeruginosa.Infect Immun1983https://conductscience.org/library/papers/6404824PubMed
5420738The differential attachment of antibiotics to glycoprotein and blood lymphocytes.J Clin Pathol1970https://conductscience.org/library/papers/5420738PubMed
5018658Treatment and prevention of pulmonary complications of cystic fibrosis in infancy and early childhood.Arch Dis Child1972https://conductscience.org/library/papers/5018658PubMed
5001942Opsonic defect in patients with cystic fibrosis of the pancreas.Proc Natl Acad Sci U S A1971https://conductscience.org/library/papers/5001942PubMed
4986284Treatment of severe pseudomonas infections of the bronchi.Br Med J1970https://conductscience.org/library/papers/4986284PubMed
4630478Bacterial infection in cystic fibrosis.Arch Dis Child1972https://conductscience.org/library/papers/4630478PubMed
4628901Pseudomonas aeruginosa: immune status in patients with cystic fibrosis.Infect Immun1972https://conductscience.org/library/papers/4628901PubMed
4211799An improved test for Haemophilus influenzae precipitins in the serum of patients with chronic respiratory disease.J Clin Pathol1974https://conductscience.org/library/papers/4211799PubMed
4200860Production and characterization of the slime polysaccharide of Pseudomonas aeruginosa.J Bacteriol1973https://conductscience.org/library/papers/4200860PubMed
4199745Significance of Pseudomonas aeruginosa in sputum.Br Med J1973https://conductscience.org/library/papers/4199745PubMed
3924607Evaluation of three serological tests for detection of antibody to Pseudomonas aeruginosa in human sera.Eur J Clin Microbiol1985https://conductscience.org/library/papers/3924607PubMed
3025179Gene algD coding for GDPmannose dehydrogenase is transcriptionally activated in mucoid Pseudomonas aeruginosa.J Bacteriol1987https://conductscience.org/library/papers/3025179PubMed

See all 30 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4170754

GET https://conductscience.org/api/papers/v1/4170754/cited_by?page=2